Project Grant R43DK143818
Award Date 9/17/25
Completion Date 9/16/26
Dollars Obligated $324K
Funding Federal Agency
Awarding Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Bellevue, WA 98004, USA
Similar Awards
- This Project Grant award, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports a study on the use of intravesical gentamicin coupled with Lactobacillus rhamnosus for urinary health. The total funding amount is $126,166.00, with the award date of September 1, 2024 and an ultimate completion date of August 31, 2027. The prime awardee is Medstar Health Research Institute Inc., a non-profit organization that has extensive...
- This Project Grant award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) program provides $305,000.00 in funding to Kapha Bio, Inc. to develop effective treatments for recurrent bacterial infections using biomimetic mucins. The broader goal is to create a library of biomimetic mucins that can restore mucosal tissue homeostasis and selectively target pathogenic microbial populations, addressing conditions like gum disease, irritable bowel...
- This federal Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), provides $294,886 to Thormed Innovation LLC to develop a wearable, wireless ultrasound bladder monitoring system. The goal is to create a reusable, non-invasive device that can accurately measure urine output, reducing the need for invasive urinary catheters which are...
- The Defense Health Agency awarded a $1,523,243 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the Medstar Health Research Institute Inc. to evaluate the use of intravesical gentamicin coupled with the probiotic Lactobacillus rhamnosus for improving urinary health. The project will involve pre-clinical studies at Loyola University of Chicago and the University of Pittsburgh to determine the optimal administration protocols, as well as a pilot clinical...
- This $117,000 Project Grant award was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), to the Research Institute at Nationwide Children's Hospital. The project aims to define the mechanisms by which the transcription factor STAT3 contributes to antimicrobial host defense in the human urothelium (bladder lining) against urinary tract infections (UTIs). Key...
- This $809,427 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports research on the impact of polymicrobial interactions and within-host adaptation on the pathogenesis of catheter-associated urinary tract infections (CAUTI). The award recipient, The Research Foundation For The State University Of New York (RF SUNY) doing business as Sponsored...
- This $3,400,004 Project Grant awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to investigate the role of waterborne Escherichia coli transmission as a cause of community-acquired urinary tract infections (UTIs). The key objectives are to: (1) model the drivers and dynamics of E. coli contamination in water systems, (2) identify socio-behavioral, epidemiological, genomic, and...
- This Project Grant award of $356,032 from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847) supports the development of a novel bladder catheterization device. The project aims to create an innovative method for bladder drainage that addresses the significant morbidity and inconvenience associated with current catheterization approaches. Over 1 million Americans, including those with neurogenic bladder conditions, require catheter use for bladder drainage. The...
- This $392,634 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports the development of a novel nanoimmunotherapeutic approach to combat multidrug-resistant (MDR) bacterial infections. The project aims to design, fabricate, and optimize a red blood cell membrane-coated, hemoglobin-encapsulating nanoparticle (RHNP) that can sensitize bacteria to host oxidant killing while...
- The Department of the Army Medical Command has awarded a $5,468,175 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the University of Utah to develop a sustained-release drug delivery device to manage biofilm implant-related infections. The project, with a performance period from May 1, 2024 to April 30, 2028, will involve the University of Utah collaborating with Purgo Scientific LLC as a sub-awardee to advance this innovative medical technology. The...